GS
65
16
FE
34
4
HAL
40
11
EXPE
83
8
MRK
25
2
PCG
59
9
GT
43
2
HST
53
4
RF
44
10
ADBE
50
3
IR
46
3
AAPL
64
3
MTCH
62
22
ADT
12
2
ES
12
3
CTSH
55
3
STZ
42
2
HSIC
42
2
SYK
50
4
NOV
45
2
GS
65
16
FE
34
4
HAL
40
11
EXPE
83
8
MRK
25
2
PCG
59
9
GT
43
2
HST
53
4
RF
44
10
ADBE
50
3
IR
46
3
AAPL
64
3
MTCH
62
22
ADT
12
2
ES
12
3
CTSH
55
3
STZ
42
2
HSIC
42
2
SYK
50
4
NOV
45
2
Financhill
Back

Lam Research Vs. Novo Nordisk AS Industry Stock Comparison

Buy
56

LRCX
Lam Research

Last Price:
$71.81
Seasonality Move:
13.44%
Sell
23

NVO
Novo Nordisk AS

Last Price:
$85.00
Seasonality Move:
6.92%
Buy
56
Lam Research (LRCX) is a Buy

Is Lam Research a Buy, Sell or Hold?

  • The current Lam Research [LRCX] share price is $71.79. The Score for LRCX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • LRCX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
23
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $85.00. The Score for NVO is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LRCX Stock Price Chart

What is Lam Research's stock price today?

  • The Lam Research share price today is $71.79
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LRCX is experiencing slight selling pressure.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $85.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight buying pressure.

LRCX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.29 Sell
Relative Strength Index (14 RSI): 42.23 Sell
Chaikin Money Flow: -1798513 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (71.57 - 77.37) Sell
Bollinger Bands (100): (73.43 - 82.05) Sell

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.5 Sell
Relative Strength Index (14 RSI): 19.69 Sell
Chaikin Money Flow: 20899665 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.63 - 110.99) Sell
Bollinger Bands (100): (107.27 - 131.41) Sell

LRCX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 75.49 Sell
20-day SMA: 75.39 Sell
50-day SMA: 75.29 Sell
200-day SMA: 87.23 Sell
8-day EMA: 74.54 Sell
20-day EMA: 75.15 Sell
50-day EMA: 76.14 Sell
200-day EMA: 81.12 Sell

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 104.71 Sell
20-day SMA: 106.65 Sell
50-day SMA: 109.28 Sell
200-day SMA: 126.25 Sell
8-day EMA: 102.07 Sell
20-day EMA: 105.53 Sell
50-day EMA: 110.02 Sell
200-day EMA: 118.09 Sell

Lam Research Earnings Growth & LRCX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $26.45 per share, and a decrease next year of $26.21 per share.

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.72 per share.

Lam Research Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):